Arabic Arabic English English French French German German
dark

Phio Pharmaceuticals Announces Regulatory Clearance of Clinical Trial for PH-762 to Treat Melanoma

Phio Pharmaceuticals Corp. today announced that it has received regulatory clearance to start a clinical trial with its lead product candidate, PH-762. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Avinger Announces 510(k) Clearance for Lightbox 3 Next-Generation Imaging Console

Next Post

Why Marijuana is Being Used for Health Benefits

Related Posts
Total
0
Share